Treatment of Tuberculosis

Autor: WW Yew

Publikováno v: Tuberculosis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::29cb1f26911523760cdcc50cc9861f76
https://doi.org/10.5005/jp/books/10992_52

Ethambutol-induced pulmonary infiltrates with eosinophilia and skin involvement

Autor: PC Wong, WW Yew, CF Wong, HY Choi

Publikováno v: The European respiratory journal. 8(5)

A 67 year old woman presented with miliary tuberculosis. She was treated with streptomycin, isoniazid, rifampicin, ethambutol and pyrazinamide. However, she developed rifampicin-induced thrombocytopenia after 6 weeks of treatment, and skin rash, bloo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::509951a96af624451fd4bdb80c097f43
https://pubmed.ncbi.nlm.nih.gov/7656964

Analyses of fluoroquinolones and Clostridium difficile-associated diarrhoea in tuberculosis patients

Autor: Kc, Chang, Cc, Leung, Ww, Yew, Fm, Lam, Pl, Ho, Ch, Chau, Vincent Chi-Chung CHENG, Ky, Yuen

Publikováno v: Europe PubMed Central

Systematic studies of fluoroquinolones (FQs) and Clostridium difficile-associated diarrhoea (CDAD) are scarce among tuberculosis (TB) patients, in whom fluoroquinolones (FQs) are increasingly used.To evaluate the relationship between FQs and CDAD amo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fa9b7cfffb50b9e27bc04dd2a9a20c8f
http://europepmc.org/abstract/med/19275794

Is there a place for anti-inflammatory therapy in COVID-19?

Autor: Yew WW; Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China., Chang KC; Tuberculosis and Chest Service, Centre for Health Protection, Department of Health, Hong Kong, China., Chan DP; Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China.

Publikováno v: Journal of thoracic disease [J Thorac Dis] 2020 Nov; Vol. 12 (11), pp. 7076-7080.

Phenotypic and Genotypic Characterization of Streptomycin-Resistant Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Southern China.

Autor: Islam MM; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China.; University of Chinese Academy of Sciences (UCAS), Beijing, China.; Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou, China., Tan Y; State Key Laboratory of Respiratory Disease, Department of Clinical Laboratory, Guangzhou Chest Hospital, Guangzhou, China., Hameed HMA; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China.; University of Chinese Academy of Sciences (UCAS), Beijing, China.; Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou, China., Chhotaray C; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China.; University of Chinese Academy of Sciences (UCAS), Beijing, China.; Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou, China., Liu Z; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China.; Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou, China., Liu Y; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China.; Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou, China., Lu Z; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China.; Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou, China., Wang S; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China.; University of Chinese Academy of Sciences (UCAS), Beijing, China.; Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou, China., Cai X; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China.; University of Chinese Academy of Sciences (UCAS), Beijing, China.; Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou, China., Gao Y; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China.; University of Chinese Academy of Sciences (UCAS), Beijing, China.; Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou, China., Cai X; State Key Laboratory of Respiratory Disease, Department of Clinical Laboratory, Guangzhou Chest Hospital, Guangzhou, China., Guo L; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China.; University of Chinese Academy of Sciences (UCAS), Beijing, China.; Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou, China., Li X; State Key Laboratory of Respiratory Disease, Department of Clinical Laboratory, Guangzhou Chest Hospital, Guangzhou, China., Tan S; State Key Laboratory of Respiratory Disease, Department of Clinical Laboratory, Guangzhou Chest Hospital, Guangzhou, China., Yew WW; Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China., Zhong N; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Liu J; State Key Laboratory of Respiratory Disease, Department of Clinical Laboratory, Guangzhou Chest Hospital, Guangzhou, China., Zhang T; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China.; University of Chinese Academy of Sciences (UCAS), Beijing, China.; Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou, China.; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Publikováno v: Microbial drug resistance (Larchmont, N.Y.) [Microb Drug Resist] 2020 Jul; Vol. 26 (7), pp. 766-775. Date of Electronic Publication: 2020 Jan 23.